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Long-Term Pulmonary Function and Quality of Life in Children After Acute Respiratory Distress Syndrome: A Feasibility Investigation
When appraising the long-term consequences of the general PICU admission, where the mortality rate is much lower at 3%, several studies have found resultant deficits in physical function, quality of life (QOL), mental health, and family function (5) (6) (7) (8) (9) (10) . Posttraumatic stress disorder (PTSD) has also been found in up to 30% of PICU survivors and seems to be associated with severity of illness, invasive procedures, and length of stay (LOS) (11) (12) (13) . It is, therefore, profoundly important to evaluate the long-term physical and psychologic consequences in pediatric ARDS survivors. Many clinicians and investigators in the pediatric and adult ARDS environments have equally noted this imperative (3, 14) .
It is our aim to complete this pilot investigation to 1) gather preliminary evidence that pediatric ARDS survivors suffer from long-term pulmonary function (PFT), physical, psychologic, and QOL deficits and 2) assist in determining the feasibility of performing larger, long-term, in-person follow-up evaluations in pediatric ARDS survivors with non-ARDS control groups.
MATERIALS AND METHODS

Patient Selection
All patients admitted to the PICU at UCSF Benioff Children's Hospital, Oakland, between August 2000 and May 2005 were prospectively evaluated and all who were diagnosed with ARDS were approached for study consent. Based on the 1994 American European Consensus Committee (AECC) definition, ARDS was defined as the presence of bilateral infiltrates on chest radiograph, no evidence of left atrial hypertension, and a Pao 2 -to-Fio 2 ratio (P-to-F ratio) of less than 300 (15) . Patients were excluded if they were less than 36 weeks corrected gestation age or more than 18 years old at onset of ARDS, were neonates with infantile respiratory distress syndrome, or had intracardiac mixing lesions. All patients had at least one arterial blood gas supporting the P-to-F ratio requirement for diagnosis. For patients who were not mechanically ventilated, the Fio 2 was calculated according to the American Association of Respiratory Care guidelines (16) . Radiographic interpretation was confirmed by independent readings from attending radiologists who were blinded to the study. The Institutional Review Board at UCSF Benioff Children's Hospital, Oakland, approved the study.
Procedures
Demographic and admission data were collected from the medical record including age, gender, race, ethnicity, past medical history, Pediatric Risk of Mortality (PRISM) III (a severity of illness score) (17) , and Pediatric Logistic Organ Dysfunction (PELOD) score (score of multiple organ dysfunction) (18) . Mechanical ventilator variables were collected throughout admission. Duration of mechanical ventilation was measured as ventilator-free days defined as the number of days a patient did not require mechanical ventilation up to 28 days from diagnosis. In this calculation, all patients who died were assigned zero ventilator-free days and all who were never intubated were assigned 28 ventilator-free days.
Once discharged, patients were followed at 6-month intervals for 2 years. All subjects were reminded about follow-up visits frequently by both telephone discussions and regularly mailed reminders. At each visit, acute health status was reviewed to ensure appropriateness for PFT testing. Both the parent and the child, where developmentally appropriate, were asked to complete the Child Health Questionnaire (CHQ; healthactchq. com). The CHQ is a generic QOL instrument that is commercially available and scored. It has been used widely in the pediatric population, including those with complex and chronic diseases, in both clinical and research settings as it has strong validity in assessing both physical and psychosocial concepts (19) . There is currently no disease-specific QOL instrument for ARDS, either in adults or in children. The CHQ concepts include general health, physical functioning, emotional and behavioral role/social limitations, physical role/social limitations, bodily pain/discomfort, general behavior, global behavior, mental health, self-esteem, and general health perception. Individual CHQ results were coded, and final scores were calculated by computing the mean of the items completed. These raw scale scores were then transformed to a 0-100 score (100 being the best possible score) for each concept. These data were also compared with National Normative and Asthma Clinical Trials CHQ results (19) available in the public domain.
PFT tests were obtained on infants up to 18 months old and in children 3 years old or older. Standard procedures for both infant and child PFT testing were applied (20, 21) . For the infant patients, the infant was sedated with chloral hydrate during PFT testing. Once asleep, the infant was placed on 100% oxygen via face mask, and nitrogen washout technique was used to obtain functional residual capacity measurements. Thereafter, they were placed in an inflatable plastic vest (the "baby hugger"), arms outside the vest, and the rapid chest compression technique was applied to obtain partial expiratory flow-volume loops. Rapid chest compressions occurred at the end of tidal inspiration. Flow was measured at the mouth by a pneumotachograph attached to the face mask. Occluding the expiratory port of the face mask at end inspiration for 200-400 ms and allowing the infant to expire passively tested passive mechanics. Airway reactivity was tested by repeating the baby hugger technique 10 minutes after nebulized albuterol administration.
For children greater than 3 years old and with appropriate developmental ability, PFT testing included spirometry and body plethysmography. Spirometry data were recorded for forced vital capacity (FVC) and forced expiratory flows (FEFs). Plethysmograph values included tidal volumes, functional residual capacity, residual volume, and diffusion capacity (DLCO). All children underwent standardized nebulized albuterol challenges to identify patients with airway reactivity, and thus possible undiagnosed obstructive disease. All PFTs were interpreted by a pediatric pulmonologist who was blinded to any patient data, including past medical history and ARDS course. Obstructive lung disease was defined as forced expiratory volume (1 s) (FEV1)/FVC of less than 0.8, or as FEF 25 of less than 70% predicted in patients with a normal FVC, and restrictive lung disease was defined as a FVC of less than 80% predicted with a normal FEV1-to-FVC ratio. Mild obstructive lung disease was defined as an FEV1 equal to 70-79% predicted, moderate as 50-69% predicted, and severe as less than 49% predicted. A diffusion defect was defined as a DLCO less than 80% predicted. A mild diffusion abnormality was defined as 60-79% predicted, moderate as 40-59% predicted, and severe as less than 40% predicted (21, 22) .
Statistical Analysis
This is a preliminary study for the purposes of determining feasibility of long-term follow-up examinations and PFT testing in children who have recently been critically ill, rather than determining statistically significant correlations between severity of ARDS and long-term PFT. Therefore, p values were not intended for interpretation as they would be in randomized, controlled clinical trials. Summary statistics were calculated for all who consented to long-term follow-up and for all who actually returned for follow-up. Comparison of demographic data between those who did and did not return for follow-up assessment was performed by Fisher exact-chi-square testing between categoric variables and Wilcoxon signed rank or Kruskal-Wallis tests for continuous variables. P-to-F ratio, PELOD score, and ventilator variables recorded 24 hours after ARDS diagnosis were used and compared by spearman correlation to PFT results. Due to few patients returning for more than one follow-up evaluation, we chose to use the PFT and CHQ data closest to the 12-month post hospital admission for those with multiple visits. We used student t tests to compare parent and child CHQ scores, and CHQ scores from the present study with normative and chronic asthma samples. We examined relationships between CHQ scores and demographic variables using Spearman correlations (for continuous variables such as education level and parent age) and analysis of variance or Student t test (for categoric variables such as single-vs doubleparent home, parental employment status, or race). All analyses were performed using STATA statistical software, version 13.1 (StataCorp, College Station, TX).
RESULTS
During the enrollment period, 180 children met AECC definitions for acute lung injury (ALI) or ARDS. Of this cohort, 37 (20%) died, 91 (51%) refused to participate in long-term followup, 28 (16%) consented but did not return despite numerous appointment reminders, and 24 (13%) returned for PFT testing and to answer CHQ QOL surveys. Of these 24, only 17 were able to successfully complete some, or all, of the PFT test portion. Seven patients and 23 parents completed the CHQ questionnaire.
There were no significant differences in gender, ethnicity, duration of mechanical ventilation, PRISM III score, P-to-F ratio, or LOS between those who returned for follow-up and those who did not, or between those who returned for follow-up and all ARDS survivors within the cohort. Patients who returned for follow-up were older than those who did not, with a median age of 5.3 years (interquartile range [IQR], [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] for those who returned for follow-up evaluation compared with a median age of 1.8 years (IQR, 0.2-5) for those who did not return (p = 0.03). The mean time to follow-up was 10.7 ± 3.9 months. Table 1 shows the demographic data of all eligible patients, those who did not consent, those who consented for follow-up but did not return, and those who consented and completed follow-up evaluation.
Of the 24 patients who did return for follow-up, two (8%) had prior diagnoses of reactive airway disease, no other patient reported a history of chronic pulmonary or neuromuscular conditions. The most common etiology of ARDS was pneumonia (n = 9; 38%) followed in frequency by sepsis (n = 4; 17%) and near drowning (n = 3; 12%) with aspiration, trauma, pulmonary hemorrhage, or transfusion-related ALI all compromising less than 10% each. Four did not require intubation and mechanical ventilation, four high-frequency oscillations, one extracorporeal life support, and the remainder used conventional mechanical ventilation for a period during their PICU admission. The median number of ventilator-free days up to 28 days from diagnosis was 22 days (IQR, [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] .
PFT Test Results
Because the mean time to follow-up was 10.7 months and because most participants returned only once, the PFTs performed nearest to the 12-month post-ARDS mark were analyzed. Of the 17 who completed PFTs, 14 had standard child and three had infant testing. The testing found that 11 (64%) had normal PFTs, two (12%) had mild obstruction, two (12%) had moderate obstruction, and two (12%) had abnormal DLCO. None exhibited restrictive disease. Of note, one of the patients with moderate obstruction and one with a DLCO deficit had reported reactive airway disease prior to admission but had been compliant with controller medications. No patient reported an emergency department visit or hospitalization for an intercurrent respiratory illness between the time of ICU discharge and PFT testing. Supplemental Table 1 (Supplemental Digital Content 1, http://links.lww.com/PCC/A373) reports the PFT results for these 17 patients.
When evaluating for any correlations between ICU events, mechanical ventilation variables, and PFT results, we found that airway resistance (R aw ) correlated negatively with P-to-F ratio calculated on day 1 of illness (n = 10; ρ = −0.66; p = 0.004) such that as P-to-F ratio worsened (smaller value) so did the R aw measured on PFTs performed after discharge. Additionally, PICU LOS appeared to have a potential correlation with increased R aw on postillness PFTs (n = 12; ρ = 0.5; p = 0.08). No other correlations between PFT results and mechanical ventilation variables (including peak inspiratory pressure, positive end-expiratory pressure, mean airway pressure, and tidal volume), PRISM III, PELOD, duration of mechanical ventilation, or length of hospital or ICU stay were found to be significant. Because the number of patients returning for PFT testing is small and because such testing may be impacted by a patient's prior comorbidities or by respiratory illnesses during the interval between ARDS and follow-up appointment, we provide such details in a descriptive Table 2 of the 17 patients who returned for PFT testing. indicating parental belief that the child's health is poor and likely to get worse. Parents also rated their child's health as worse now than 1 year ago (general health mean, 63 ± 22). Parent scores for their children on the physical functioning (mean, 77 ± 22) and general behavior (mean, 75 ± 14) scales were in the moderate range. Parents rated children as highest on role/social limitations-behavior (mean, 88 ± 22) and self-esteem (mean, 86 ± 14). Figure 1 demonstrates all parents' responses as well as matched parent and patient (n = 7) responses on the CHQ assessment. Although there is insufficient number of comparisons to make statistical inferences in these seven parent-patient responses, we found that, except for social limitations-physical and behavior, children generally reported better long-term health across many domains (general health, bodily pain, mental health and general health perceptions) compared with their parents.
QOL Assessment
Comparison to National Asthma Clinical Trials and National Normative CHQ Cohorts. Parent CHQ ratings for their children who were pediatric ARDS survivors in the present study reported significantly decreased "physical functioning, role physical" and "worse general health perceptions" (p < 0.05) when compared with both Asthma Clinical Trial and National Normative samples of U.S. children whose parents completed the CHQ (Fig. 2) . Remaining scales (behavior, mental health, bodily pain, self-esteem) were on par across all cohorts compared.
Relationships Between CHQ Scores and Demographics. Parental reports indicated diminished mental health (−0.78; p = 0.01) and a trend toward diminished role/social limitationsemotional (−0.60; p = 0.07) scores in children of increasing grade level. Parents with a higher level of education reported lower bodily pain in their child (ρ = −0.44; p = 0.03). Single parenting was also associated with a trend toward higher ratings of general 
DISCUSSION
Several adult studies have shown deficits in DLCO, airflow obstruction, restrictive lung disease, or persistent hypoxemia even 6-12 months after hospital discharge (23) (24) (25) . The few studies that have been published evaluating the PFT in children after ARDS are small series studies (n = 7; n = 9; n = 5; n = 11), all performed before lung-protective mechanical ventilation strategies were used and, therefore, most children included in the prior research reports were exposed to much higher ventilator settings than are currently preferred (26) (27) (28) (29) (30) (31) . From these early publications, it seems that ARDS in children leads to similar pulmonary deficits as seen in adults with ARDS. Although a pilot investigation, our study of 24 patients represents one of the largest cohorts of pediatric ARDS survivors with long-term follow-up evaluations to date. Although onethird of our patients exhibited deficits on PFT testing, most did not have pulmonary sequelae of grave nature. It is interesting that no patient was noted to have restrictive lung disease given ARDS is, for the most part, a parenchymal disease. Several adult studies note a similar finding and report obstructive disease and DLCO deficits as often as restrictive disease (23) (24) (25) , begging the question whether prolonged pulmonary dysfunction is from the disease itself or from the use of mechanical ventilation in addition to the presence of diseased lung parenchyma. Two of the six patients with abnormal PFT results had prior pulmonary disease that may have contributed to their risk of developing ARDS and to their prolonged pulmonary dysfunction. No patient reported intercurrent pulmonary illnesses or pulmonary-related hospitalizations in the period between ARDS hospitalization and time of testing. Although the number of patients in our study makes it difficult to provide strict conclusions between ARDS and prolonged pulmonary dysfunction, it is important for the primary care providers and outpatient pulmonologists to be aware of the high potential of prolonged PFT deficits after ARDS, particularly in those with chronic risk factors.
Aside from prolonged pulmonary dysfunction, there is significant evidence that ARDS results in long-term consequences in adult survivors, including global cognitive delay, anxiety, depression, and PTSD (32) (33) (34) (35) (36) . Although long-term QOL outcomes have recently become an area of focus in the general PICU population, there have been no studies solely focusing on the long-term effect of ARDS on children's neurocognitive outcome. Knoester et al (9, 37) reported only 31% of PICU survivors having normal Pediatric Overall Performance Category (POPC) at 3 months postdischarge, highlighting substantial physical sequelae in these survivors of critical illness. In 2009, Colville and Pierce (38) documented that PICU survivors again reported lower physical function scores, but no significant association between severity of PICU illness and QOL scores at 1 year. Focusing solely on the impact of ARDS on aspects of QOL, a multicenter trial of prone positioning in children with ARDS revealed that the POPC scale worsened from admission to discharge in 22% of survivors, whereas 17% of survivors had worsened Pediatric Cerebral Performance Category scales (39, 40) . This study, however, did not evaluate performance or QOL outcomes after discharge. Our QOL testing indicates that after hospitalization for ARDS, children describe a remarkable resilience of spirit, yet parents and caregivers note a significant decrease in overall physical functioning and concerning global health discrepancies compared with their peers. Because our study did not have a control group of critically ill children admitted to the PICU for non-ARDS diagnoses, further investigation will be needed to discern QOL burdens secondary to ARDS and prolonged mechanical ventilation compared with critical illness alone. Long-term neurocognitive outcome data from large multicenter studies like RESTORE Cog (https://clinicaltrials. gov/show/NCT02225041), focusing particularly on mechanically ventilated pediatric ARDS and non-ARDS patients, will no doubt shed important light on this finding and lead the next therapeutic, diagnostic, and research initiatives in this area.
Our findings reveal that social stressors may impact aspects of QOL after ARDS. Parents with a lower level of education and those in single-parent families reported greater bodily pain in their child compared with their peers. This association is certainly not unique to ARDS and has been reported in several disease entities after prolonged ICU stay. In a systematic review of QOL assessments of children after ICU admission, they found significant ongoing morbidity after discharge with key determinants of poor QOL including reason for admission (i.e., severity of illness), prior comorbidities, need for invasive therapy, but also parental characteristics, particularly low socioeconomic status and parent education level (5) . Some of our data are consistent with this systematic review and support the recently published Pediatric ALI Consensus Conference encouraging assessment of long-term morbidity after ARDS. Furthermore, it reinforces the importance of counseling to, and by, the primary care providers of children with ARDS, or any critical illness, that long-term physical and QOL deficits are to be monitored closely and addressed, especially in highrisk populations such as those with chronic illness or with parents with significant socioeconomic strain.
Although our study population is small, with the number of patients who returned for follow-up being far less than the number who survived their ARDS, we do believe these data presented are novel and the results important for future long-term outcome study design. This finding of poor return for follow-up plagues most long-term outcomes research. However, in our study, there were no statistical differences between patients eligible for followup evaluation, patients who consented for the study and those who actually completed the study in the categories of gender, ethnicity, LOS, ventilator duration, severity of illness, or presence of pre-ARDS comorbidities. Although this does not eliminate all selection biases, it does show that it might be possible to generalize "in-person" follow-up data to those who could not return in this and in future studies. As such, a potential future, novel approach to long-term follow-up studies could be used, with a two pronged approach-one "traditional limb" where patients return for in-person evaluation and the other "alternate limb" where patients are assessed via video or teleconference at home or the primary care provider's office, as long as privacy can be maintained.
Our feasibility study identified other limitations as well. PFT testing is a lengthy process and requires patients to be developmentally appropriate to follow commands. As such, patients with cognitive impairments and of preschool age were unable to participate. Newer methods of PFT testing, such as impulse oscillometry (41, 42) , are more suited to children of preschool age and may provide more options in future studies. Additionally, patients with chronic pulmonary or neuromuscular comorbidities may have had some pre-ARDS PFT abnormalities and interpreting the PFT results, and the impact of ARDS on long-term PFT must take such comorbidities into consideration. With regard to our CHQ testing, there is no published QOL assessment tool specific for the pediatric ARDS cohort. Furthermore, although the CHQ format was quite extensive, it did not assess for PTSD or include methods to assess physical functioning, such as a 6-minute walk. Additionally, with there being no validated QOL assessment tool for pediatric critical illness or ARDS, we chose the CHQ format because of its validation of chronic pulmonary diseases, such as asthma, and of children after prolonged hospitalization for any illness. A potential strategy to reduce this limitation in the future is to ask parents to complete the questionnaire at time of admission to the ICU and again at follow-up appointments so that matched comparisons can be analyzed and reduce prehospitalization factors.
Overall, this feasibility study describes the challenge of having a majority of survivors of pediatric ARDS return to their tertiary center of referral for extensive long-term outcome testing; yet despite incomplete follow-up, valuable information may be obtained from those who return for postdischarge evaluation. In this cohort of 24 children who returned for follow-up after hospitalization for ARDS, one-third exhibited mild to moderate impairments in PFT approximately 10 months after ARDS diagnosis, and abnormal PFTs were observed in both children who required mechanical ventilation and those who did not. Additionally, at first glance, it appears that the ARDS patients do fairly well after their admission; however, in comparison to national norms and other children with impaired lung health (asthma), it is clear that pediatric survivors of ARDS are impacted across many QOL domains, particularly general health perception, physical functioning, and behavior. More research and information in this area are imperative to inform healthcare providers who can help direct and authorize additional services and treatments to enable as much recovery as possible and to engage and empower the families of these children that must deal with the socioeconomic concerns and stressors these additional morbidities yield.
